JM Canty International and NIBRT Team Up for Optical System Research Collaboration

September 27, 2019
Pharmaceutical Technology Editors

The companies plan to collaborate for the advancement of an optical system for on-line analysis of mammalian cells during a bioprocess.

JM Canty International, a fused sight glass company headquartered in Buffalo, NY, and the National Institute for Bioprocessing Research and Training (NIBRT) announced a research collaboration for the advancement of an optical system for on-line analysis of mammalian cells during a bioprocess.

The Enterprise Ireland-funded collaboration will use a Pharmaflow imaging system that will monitor cell viability in real time with high resolution, without the need for a cell stain, according to a Sept. 27, 2019 press release. Cantyvision software will capture information on cell morphology, including roundness and granularity, while remaining non-destructive to the sample because of the constant analysis of bench-top bioreactors. 

The research will be led by Michael Butler, a professor at NIBRT, and will include two members of the NIBRT Cell Technology team and a newly appointed post-doctoral researcher. 

“This collaboration will enable us to use the high-resolution optical system developed by Canty in advanced monitoring and control protocols for bioprocesses to produce therapeutic proteins and other cellular therapies,” said Butler in the press release. 

Source: NIBRT